E
EnPlusOne Bio provides a flexible enzymatic platform designed to scale the manufacturing of RNA therapeutics. This platform increases synthesis capacity and cycle efficiencies for producing high-purity, long RNA molecules. The technology enables access to a broader RNA design space by incorporating novel chemical modifications beyond those currently accessible via standard synthesis.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- EnPlusOne Bio provides a flexible enzymatic platform designed to scale the manufacturing of RNA therapeutics. This platform increases synthesis capacity and cycle efficiencies necessary for producing high-purity, long RNA molecules. By enabling access to a broader RNA design space, the company supports the development of novel therapeutics utilizing natural RNA modifications.